Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionMercer Global Advisors Inc /adv
Latest Disclosed Ownership80,018 shares
Latest Disclosed Value $ 3,225,508
Mercer Global Advisors Inc /adv reports 20.79% decrease in ownership of HTD / Corcept Therapeutics Incorporated

On May 15, 2026 - Mercer Global Advisors Inc /adv filed a 13F-HR form disclosing ownership of 80,018 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $2,759,821 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 101,022 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -20.79% during the quarter. The current value of the position is $5,060,338 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 80,018 -21,004 -20.79 3,226 -8.25 0.0048
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 101,022 -6,212 -5.79 3,516 -60.56 0.0054
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 107,234 -12,758 -10.63 8,912 1.19 0.0149
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 119,992 14,405 13.64 8,807 -26.97 0.0179
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 105,587 15,884 17.71 12,060 166.81 0.0277
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 89,703 -71 -0.08 4,520 7.72 0.0110
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 89,774 7,973 9.75 4,197 57.92 0.0098
2024-08-12 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 81,801 10,658 14.98 2,658 265,600.00 0.0072
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 71,143 -3,537 -4.74 2 -50.00 0.0051
2024-02-15 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 74,680 7,387 10.98 2 100.00 0.0073
2023-11-15 2023-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 67,293 14,644 27.81 2 0.00 0.0070
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 67,293 14,644 2 0.0070
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 52,649 7,459 16.51 1 0.0046
2023-05-16 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 45,190 3,326 7.94 1 0.0044
2023-02-09 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 41,864 799 1.95 1 -100.00 0.0043
2022-11-15 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 41,065 3,285 8.70 1,053 17.26 0.0062
2022-08-10 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 37,780 4,817 14.61 898 21.02 0.0055
2022-05-10 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 32,963 6,760 25.80 742 42.97 0.0044
2022-02-04 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 26,203 2,964 12.75 519 13.57 0.0032
2021-11-10 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 23,239 1,445 6.63 457 -4.59 0.0032
2021-08-10 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 21,794 1,543 7.62 479 -0.62 0.0037
2021-08-10 2021-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 20,251 2,145 11.85 482 1.69 0.0044
2021-05-11 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 20,251 2,145 482 0.0046
2021-02-12 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 18,106 2,685 17.41 474 76.87 0.0059
2020-12-10 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 15,421 3,222 26.41 268 30.73 0.0040
2020-08-10 2020-06-30 13F CORCEPT THERAPEUTICS INC COM 218352102 12,199 12,199 205 0.0037
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.